Serum AZD7442 (tixagevimab-cilgavimab) concentrations and in vitroIC50 values predict SARS-CoV-2 neutralising antibody titres. - Clegg LE; Stepanov O; Matthews S; White T; Seegobin S; Thomas S; Tuffy KM; Någård M; Esser MT; Streicher K; Cohen TS; Aksyuk AA (Clinical & translational immunology, 2024)